Le Lézard
Classified in: Health
Subjects: LEG, VET

Commander John Scott Hannon Act Signed into Law


WASHINGTON, Oct. 20, 2020 /PRNewswire/ -- Through bipartisan effort and significant advocacy efforts from Wounded Warrior Project® (WWP), major legislation has been signed into law that will provide new treatments for warriors dealing with post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). The newly signed law is designed to reduce suicides and increase resilience, especially in underserved areas.

Among its key provisions, the law will:

"We are thankful for the tireless efforts and bi-partisan leadership of Senators Jerry Moran and Jon Tester and Representatives Mark Takano and Phil Roe," said WWP CEO Lt. Gen. (Ret.) Mike Linnington. "Without their collective support, and that of warriors across the country, the Commander John Scott Hannon Veterans Mental Health Care Improvement Act would not have passed. I offer a huge thank you to those warriors for making their voices heard to our leaders in Congress."

Wounded Warrior Project invited warriors from across the country to Washington, D.C. in February to advocate for the passage of this act. Additionally, WWP:

Read more about the legislation here. Learn more about WWP's other legislative priorities and how we work with our nation's leaders to improve the lives of wounded veterans and their families.

About Wounded Warrior Project
Since 2003, Wounded Warrior Project® (WWP) has been meeting the growing needs of warriors, their families, and caregivers ? helping them achieve their highest ambition. Learn more.

SOURCE Wounded Warrior Project


These press releases may also interest you

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...



News published on and distributed by: